Delivery Order SPE2DB22D9310-SPE2DB25FP0LS

Award Date 3/25/25
Potential Completion Date 3/26/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $2,075.43 issued under the Defense Logistics Agency's (DLA) SPE2DB pharmaceutical supply program. The award, which has a completion date of May 22, 2024, is for the supply of Armour Thyroid 60 mg tablets. DMS Pharmaceutical Group is a key supplier to the Department of Defense (DoD) and Department of Veterans Affairs (VA), providing a wide range of pharmaceutical products...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $1,259.88 and covers the delivery of Armour Thyroid 120 mg tablets. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a wide range of pharmaceutical products to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract worth $1,159.83 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of Armour Thyroid 30 mg tablets in 100-count bottles. This order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract #4600082013 with DLA, which has a ceiling value of up to $4,999,999 and enables DLA to issue delivery orders for a wide...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,259.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Armour Thyroid 120 mg tablets, which are a specialized pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,470.90 firm fixed-price delivery order is for the supply of Armour Thyroid 120 mg tablets. The contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,259.88 and covers the delivery of Armour Thyroid 120 mg tablets over a period ending on February 10, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,464.30 contract is for the delivery of Armour Thyroid 90 mg tablets. The contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,374.48 firm fixed-price delivery order is for the supply of Armour Thyroid 60 mg tablets in 100-count bottles. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $1,259.88, is for the delivery of Armour Thyroid 120 mg tablets in 100-count packages. This delivery order is issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to place orders for a wide range of pharmaceutical products, including...
This is a firm fixed-price delivery order valued at $1,339.00 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for 4,556,231,977 units of Armour Thyroid 30 mg tablets. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm fixed-price delivery orders for a...
  • SPE2DB22D9310
    Indefinite Delivery Contract
  • SPE2DB22D9310-SPE2DB25FP0LS
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides delivery orders for a range of pharmaceutical products to support the medical supply needs of military healthcare facilities. The $1,259.88 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) and is not associated with a set-aside designation.

The contract covers the delivery of Armour Thyroid 120 mg tablets in 100-count packages, with a performance period through March 2025. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to the Department of Defense (DoD). The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide.

Generated 6/24/25, 10:03 AM